Setting Occupational Exposure Limits for Chemical Allergens-Understanding the Challenges

Journal of Occupational and Environmental Hygiene

Volumn 12, Issue , 2015, Pages S82-S98

  Dotson, G S ^a   Maier, A ^a,b   Siegel, P D ^a   Anderson, S E ^a   Green, B J ^a   Stefaniak, A B ^a   Codispoti, C D ^c   Kimber, I ^d  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

allergens; asthma; chemicals; exposure; occupational; sensitization

Indexed keywords

ALLERGEN;

ADVERSE EFFECTS; CHEMICALLY INDUCED; DOSE RESPONSE; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; RISK ASSESSMENT; STANDARDS; THRESHOLD LIMIT VALUE;

ALLERGENS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RISK ASSESSMENT; THRESHOLD LIMIT VALUES;

EID: 84947570613     PISSN: 15459624     EISSN: 15459632     Source Type: Journal    
DOI: 10.1080/15459624.2015.1072277     Document Type: Article

References (113)

1. Kimber, I., D.A. Basketter, R.J. Dearman.: Chemical allergens-what are the issues Toxicology 268 (3): 139-142 (2010).
2. Kimber, I., D.A. Basketter., J.P. Thyssen., R.J. Dearman, J.P. McFadden.: Chemical allergy in humans: fresh perspectives. J. Immunotoxicol. 11 (3): 203-204 (2014).
3. Janeway, C.A. Jr, P. Travers.: Allergy and hypersensitivity. In Immunobiology: The Immune System in Health and Disease. New York: Garland Publishing Inc., 1997. pp. 1211-1125.
4. Kimber, I., D.A. Basketter., G.F. Gerberick., C.A. Ryan, R.J. Dearman.: Chemical allergy: translating biology into hazard characterization. Toxicol. Sci. 120 Suppl 1: S238-268 (2011).
5. Enk, A.H.: Allergic contact dermatitis: understanding the immune response and potential for targeted therapy using cytokines. Mol. Med. Today 3 (10): 423-428 (1997).
6. Gerberick, G.F., C.A. Ryan., P.S. Kern. et al.: Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods. Dermatitis 16 (4): 157-202 (2005).
7. Kern, P.S., G.F. Gerberick., C.A. Ryan., I. Kimber., A. Aptula, D.A. Basketter.: Local lymph node data for the evaluation of skin sensitization alternatives: a second compilation. Dermatitis 21 (1): 8-32 (2010).
8. Santos, R, A. Goossens.: An update on airborne contact dermatitis: 2001-2006. Contact Dermatitis 57 (6): 353-360 (2007).
9. Lalko, J.F., I. Kimber., R.J. Dearman., G.F. Gerberick., K. Sarlo, A.M. Api.: Chemical reactivity measurements: potential for characterization of respiratory chemical allergens. Toxicol. In Vitro 25 (2): 433-445 (2011).
10. Quirce, S, J.A. Bernstein.: Old and new causes of occupational asthma. Immunol. Allergy Clin. North Am. 31 (4): 677-698 (2011).
11. Quirce, S, J. Sastre.: New causes of occupational asthma. Curr. Opin. Allergy Clin. Immunol. 11 (2): 80-85 (2011).
12. Zacharisen, M.C, J.N. Fink.: Hypersensitivity pneumonitis and related conditions in the work environment. Immunol. Allergy Clin. North Am. 31 (4): 769-786 (2011).
13. Maier, A., M.J. Vincent., B. Gadagbui. et al.: Integrating asthma hazard characterization methods for consumer products. Regul. Toxicol. Pharmacol. 70 (1): 37-45 (2014).
14. Mapp, C.E., P. Boschetto., P. Maestrelli, L.M. Fabbri.: Occupational asthma. Am. J. Respir. Crit. Care Med. 172 (3): 280-305 (2005).
15. Casas, L, B. Nemery.: Irritants and asthma. Eur. Respir. J. 44 (3): 562-564 (2014).
16. Dumas, O., E. Laurent., J. Bousquet. et al.: Occupational irritants and asthma: an Estonian cross-sectional study of 34 000 adults. Eur. Respir. J. 44 (3): 647-656 (2014).
17. Vizcaya, D., M.C. Mirabelli., J.-M. Antó., et al.: A workforce-based study of occupational exposures and asthma symptoms in cleaning workers. Occup. Environ. Med. 68 (12): 914-919 (2011).
18. Baur, X., P. Bakehe, H. Vellguth.: Bronchial asthma and COPD due to irritants in the workplace-an evidence-based approach. J. Occup. Med. Toxicol. 7 (1): 19 (2012).
19. Kogevinas, M., J.P. Zock., D. Jarvis. et al.: Exposure to substances in the workplace and new-onset asthma: An international prospective population-based study (ECRHS-II). Lancet 370 (9584): 336-341 (2007).
20. Smith, A.M.: The epidemiology of work-related asthma. Immunol. Allergy Clin. North Am. 31 (4): 663-675 (2011).
21. Tarlo, S.M, C. Lemiere.: Occupational asthma. N. Engl. J. Med. 370 (7): 640-649 (2014).
22. Torén, K, P.D. Blanc.: Asthma caused by occupational exposures is common-a systematic analysis of estimates of the population-attributable fraction. BMC Pulm. Med. 9 (1): 7 (2009).
23. Mazurek, J.M., G.E. Knoeller., J.E. Moorman, E. Storey.: Occupational Asthma Incidence: Findings from the Behavioral Risk Factor Surveillance System Asthma Call-Back Survey-United States, 2006-2009. Journal of Asthma 50 (4): 390-394 (2013).
24. Arts, J.H.E., C. Mommers, C. de Heer.: Dose-response relationships and threshold levels in skin and respiratory allergy. Crit. Rev. Toxicol. 36 (3): 219-251 (2006).
25. Thierse, H.J., K. Gamerdinger., C. Junkes., N. Guerreiro, H.U. Weltzien.: T cell receptor (TCR) interaction with haptens: metal ions as non-classical haptens. Toxicology 209 (2): 101-107 (2005).
26. Wang, Y, S. Dai.: Structural basis of metal hypersensitivity. Immunol. Res. 55 (1-3): 83-90 (2013).
27. Green, B.J, D.H. Beezhold.: Industrial fungal enzymes: an occupational allergen perspective. J. Allergy (Cairo) 2011: 1-11 (2011).
28. Heederik, D.: Are we closer to developing threshold limit values for allergens in the workplace Curr. Opin. Allergy Clin. Immunol. 1 (2): 185-189 (2001).
29. Baur, X.: I are we closer to developing threshold limit values for allergens in the workplace Ann. Allergy Asthma Immunol. 90 (5 Suppl 2): 11-18 (2003).
30. Rijnkels, J.M., T. Smid., E.C. Van den Aker. et al.: Prevention of work-related airway allergies; summary of the advice from the Health Council of the Netherlands. Allergy 63 (12): 1593-1596 (2008).
31. Dankovic, D.A., B.D. Naumann., A. Maier., M.L. Dourson, L. Levy.: The scientific basis of uncertainty factors used in setting occupational exposure limits. J. Occup. Environ. Hyg. 12 (0): S55-S68 (2015).
32. Deveau, M., C.-P. Chen., G. Johanson. et al.: The global landscape of occupational exposure limits-Implementation of harmonization principles to guide limit selection. J. Occup. Environ. Hyg. 12 (0): S127-S144 (2015).
33. Wheeler, M.W., R. Park., A.J. Bailer, C. Whittaker.: Historical context and recent advances in exposure-response estimation for deriving occupational exposure limits. J. Occup. Environ. Hyg. 12 (0): S7-S17 (2015).
34. Lockey, J.E., C.A. Redlich., R. Streicher. et al.: Isocyanates and human health: multistakeholder information needs and research priorities. J. Occup. Environ. Med. 57 (1): 44-51 (2015).
35. Karlberg, A.T., M.A. Bergstrom., A. Borje., K. Luthman, J.L. Nilsson.: Allergic contact dermatitis-Formation, structural requirements, and reactivity of skin sensitizers. Chem. Res. Toxicol. 21 (1): 53-69 (2008).
36. Maestrelli, P., P. Boschetto., L.M. Fabbri, C.E. Mapp.: Mechanisms of occupational asthma. J. Allergy Clin. Immunol. 123 (3): 531-544 (2009).
37. De Vooght, V., V. Hox., B. Nemery, J.A. Vanoirbeek.: Mechanisms of occupational asthma caused by low-molecular-weight chemicals. In Occupational Asthma, T. Sigsgaard. and D. Heederik. (eds.). Basel, Switzerland: Birkhaüser Basel, 2010. pp. 141-162.
38. Farahani, R., R. Sherkat., M.G. Hakemi., N. Eskandari, R. Yazdani.: Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma. Adv. Biomed. Res. 3: 127 (2014).
39. Kimber, I., R.J. Dearman., D.A. Basketter, D.R. Boverhof.: Chemical respiratory allergy: reverse engineering an adverse outcome pathway. Toxicology 318: 32-39 (2014).
40. Holsapple, M.P., D. Jones., T.T. Kawabata. et al.: Assessing the potential to induce respiratory hypersensitivity. Toxicol. Sci. 91 (1): 4-13 (2006).
41. Kimber, I, R.J. Dearman.: What makes a chemical a respiratory sensitizer Curr. Opin. Allergy Clin. Immunol. 5 (2): 119-124 (2005).
42. Kimber, I., D.A. Basketter., G.F. Gerberick, R.J. Dearman.: Allergic contact dermatitis. Int. Immunopharmacol. 2 (2-3): 201-211 (2002).
43. Bourrain, J.L.: Occupational contact urticaria. Clin. Rev. Allergy Immunol. 30 (1): 39-46 (2006).
44. Dhingra, N., A. Shemer., J. Correa da Rosa. et al.: Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response. J. Allergy Clin. Immunol. 134 (2): 362-372 (2014).
45. Martin, S.F., P.R. Esser., F.C. Weber. et al.: Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. Allergy 66 (9): 1152-1163 (2011).
46. DeKruyff, R.H., S. Yu., H.Y. Kim, D.T. Umetsu.: Innate immunity in the lung regulates the development of asthma. Immunol. Rev. 260 (1): 235-248 (2014).
47. Yu, S., H.Y. Kim., Y.J. Chang., R.H. DeKruyff, D.T. Umetsu.: Innate lymphoid cells and asthma. J. Allergy Clin. Immunol. 133 (4): 943-950; quiz. 951 (2014).
48. Kai, W., X.U. Qian, W.U. Qun.: MicroRNAs and asthma regulation. Iran J. Allergy Asthma Immunol. 14 (2): 120-125 (2015).
49. Banks, D.E., R.J. Rando, H.W. Barkman., Jr.: Persistence of toluene diisocyanate-induced asthma despite negligible workplace exposures. Chest 97 (1): 121-125 (1990).
50. OBrien, I.M., M.G. Harries., P.S. Burge, J. Pepys.: Toluene di-isocyanate-induced asthma. I. Reactions to TDI, MDI, HDI and histamine. Clin. Allergy 9 (1): 1-6 (1979).
51. Vandenplas, O.: Reduction of exposure in the management of occupational asthma. Curr. Opin. Allergy Clin. Immunol. 11 (2): 75-79 (2011).
52. Kimber, I., R. Agius., D.A. Basketter. et al.: Chemical respiratory allergy: opportunities for hazard identification and characterisation. The report and recommendations of ECVAM workshop 60. Altern. Lab. Anim. 35 (2): 243-265 (2007).
53. Zhang, X.D., M.E. Andrew., A.F. Hubbs, P.D. Siegel.: Airway responses in Brown Norway rats following inhalation sensitization and challenge with trimellitic anhydride. Toxicol. Sci. 94 (2): 322-329 (2006).
54. Zhang, X.D., J.S. Fedan., D.M. Lewis, P.D. Siegel.: Asthmalike biphasic airway responses in Brown Norway rats sensitized by dermal exposure to dry trimellitic anhydride powder. J. Allergy Clin. Immunol. 113 (2): 320-326 (2004).
55. Zhang, X.D., A.F. Hubbs, P.D. Siegel.: Changes in asthma-like responses after extended removal from exposure to trimellitic anhydride in the Brown Norway rat model. Clin. Exp. Allergy 39 (11): 1746-1753 (2009).
56. Pauluhn, J, A. Poole.: Brown Norway rat asthma model of diphenylmethane-4,4-diisocyanate (MDI): determination of the elicitation threshold concentration of after inhalation sensitization. Toxicology 281 (1-3): 15-24 (2011).
57. Pauluhn, J., R. Dearman., J. Doe., P. Hext, T.D. Landry.: Respiratory hypersensitivity to diphenylmethane-4,4-diisocyanate in guinea pigs: comparison with trimellitic anhydride. Inhal. Toxicol. 11 (3): 187-214 (1999).
58. Arts, J.H, C.F. Kuper.: Animal models to test respiratory allergy of low molecular weight chemicals: a guidance. Methods 41 (1): 61-71 (2007).
59. Manetz, T.S, B.J. Meade.: Development of a flow cytometry assay for the identification and differentiation of chemicals with the potential to elicit irritation, IgE-mediated, or T cell-mediated hypersensitivity responses. Toxicol. Sci. 48 (2): 206-217 (1999).
60. Sastre, J., M. Fernandez-Nieto., A. Novalbos., M. De Las Heras., J. Cuesta, S. Quirce.: Need for monitoring nonspecific bronchial hyperresponsiveness before and after isocyanate inhalation challenge. Chest 123 (4): 1276-1279 (2003).
61. Pronk, A., L. Preller., M. Raulf-Heimsoth. et al.: Respiratory symptoms, sensitization, and exposure response relationships in spray painters exposed to isocyanates. Am. J. Respir. Crit. Care Med. 176 (11): 1090-1097 (2007).
62. Malo, J.L., H. Ghezzo, R. Elie.: Occupational asthma caused by isocyanates: patterns of asthmatic reactions to increasing day-to-day doses. Am. J. Respir. Crit. Care Med. 159 (6): 1879-1883 (1999).
63. Banks, D.E., J. Sastre., B.T. Butcher. et al.: Role of inhalation challenge testing in the diagnosis of isocyanate-induced asthma. Chest 95 (2): 414-423 (1989).
64. Cassidy, L.D., D.M. Molenaar., J.A. Hathaway. et al.: Trends in pulmonary function and prevalence of asthma in hexamethylene diisocyanate workers during a 19-year period. J. Occup. Environ. Med. 52 (10): 988-994 (2010).
65. Butcher, B.T., J.E. Salvaggio., H. Weill, M.M. Ziskind.: Toluene diisocyanate (TDI) pulmonary disease: immunologic and inhalation challenge studies. J. Allergy Clin. Immunol. 58 (1 PT 1): 89-100 (1976).
66. Kimber, I., J. Hilton., D.A. Basketter, R.J. Dearman.: Predictive testing for respiratory sensitization in the mouse. Toxicol. Lett. 86 (2-3): 193-198 (1996).
67. Bello, D., C.A. Herrick., T.J. Smith. et al.: Skin exposure to isocyanates: reasons for concern. Environ. Health Perspect. 115 (3): 328-335 (2007).
68. Redlich, C.A.: Skin exposure and asthma: is there a connection Proc. Am. Thorac. Soc. 7 (2): 134-137 (2010).
69. Redlich, C.A, C.A. Herrick.: Lung/skin connections in occupational lung disease. Curr. Opin. Allergy Clin. Immunol. 8 (2): 115-119 (2008).
70. Petsonk, E.L., M.L. Wang., D.M. Lewis., P.D. Siegel, B.J. Husberg.: Asthma-like symptoms in wood product plant workers exposed to methylene diphenyl diisocyanate. Chest 118 (4): 1183-1193 (2000).
71. Kimber, I, R.J. Dearman.: Chemical respiratory allergy: role of IgE antibody and relevance of route of exposure. Toxicology 181-182: 311-315 (2002).
72. Johnson, V.J., J.M. Matheson, M.I. Luster.: Animal models for diisocyanate asthma: answers for lingering questions. Curr. Opin. Allergy Clin. Immunol. 4 (2): 105-110 (2004).
73. Vanoirbeek, J.A., M. Tarkowski., J.L. Ceuppens., E.K. Verbeken., B. Nemery, P.H. Hoet.: Respiratory response to toluene diisocyanate depends on prior frequency and concentration of dermal sensitization in mice. Toxicol. Sci. 80 (2): 310-321 (2004).
74. Karlberg, A.T., K. Magnusson, U. Nilsson.: Air oxidation of d-limonene (the citrus solvent) creates potent allergens. Contact Dermatitis 26 (5): 332-340 (1992).
75. Bello, D., S.R. Woskie., R.P. Streicher. et al.: Polyisocyanates in occupational environments: a critical review of exposure limits and metrics. Am. J. Ind. Med. 46 (5): 480-491 (2004).
76. National Research Council.: Exposure Science in the 21st Century: A Vision and a Strategy. Washington, DC: The National Academies Press, 2012.
77. Pauluhn, J, U. Mohr.: Experimental approaches to evaluate respiratory allergy in animal models. Exp. Toxicol. Pathol. 56 (4-5): 203-234 (2005).
78. Arts, J.H., W.H. de Jong., J.J. van Triel. et al.: The respiratory local lymph node assay as a tool to study respiratory sensitizers. Toxicol. Sci. 106 (2): 423-434 (2008).
79. Kimber, I., D.A. Basketter., J.P. McFadden, R.J. Dearman.: Characterization of skin sensitizing chemicals: a lesson learnt from nickel allergy. J. Immunotoxicol. 8 (1): 1-2 (2011).
80. Boverhof, D.R., B.B. Gollapudi., J.A. Hotchkiss., M. Osterloh-Quiroz, M.R. Woolhiser.: A draining lymph node assay (DLNA) for assessing the sensitizing potential of proteins. Toxicol. Lett. 193 (2): 144-151 (2010).
81. Dearman, R.J., C.J. Betts., N. Humphreys. et al.: Chemical allergy: considerations for the practical application of cytokine profiling. Toxicol. Sci. 71 (2): 137-145 (2003).
82. Pauluhn, J.: Development of a respiratory sensitization/elicitation protocol of toluene diisocyanate (TDI) in Brown Norway rats to derive an elicitation-based occupational exposure level. Toxicology 319: 10-22 (2014).
83. Pauluhn, J.: Derivation of occupational exposure levels (OELs) of Low-toxicity isometric biopersistent particles: how can the kinetic lung overload paradigm be used for improved inhalation toxicity study design and OEL-derivation Part Fibre Toxicol. 11 (1): 72 (2014).
84. Anderson, S.E., P.D. Siegel, B.J. Meade.: The LLNA: a brief review of recent advances and limitations. J. Allergy (Cairo) 2011: 1-10 (2011).
85. Griem, P.: Uncertainty factors and risk assessment for skin sensitizers. In IPCS Harmonization Project Document No. 5: Skin Sensitization in Chemical Risk Assessment. Geneva: World Health Organization, 2008. pp. 46-53.
86. Kuper, C.F., W.H. Heijne., M. Dansen. et al.: Molecular characterization of trimellitic anhydride-induced respiratory allergy in Brown Norway rats. Toxicol. Pathol. 36 (7): 985-998 (2008).
87. Kuper, C.F., R.H. Stierum., A. Boorsma. et al.: The contact allergen dinitrochlorobenzene (DNCB) and respiratory allergy in the Th2-prone Brown Norway rat. Toxicology 246 (2-3): 213-221 (2008).
88. Environmental Protection Agency.: " Guidance on Cumulative Risk Assessment of Pesticide Chemicals that Have a Common Mechanism of Toxicity." Available at http://www.epa.gov/pesticides/trac/science/cumulativeguidance.pdf.
89. Environmental Protection Agency.: " Organophosphorus Cumulative Risk Assessment: 2006 Update." Available at http://www.epa.gov/pesticides/cumulative/2006-op/opcramain.pdf.
90. Environmental Protection Agency.: " Development of a Relative Potency Factor (RPF) Approach for Polycyclic Aromatic Hydrocarbon (PAH) Mixtures." Available at http://cfpub.epa.gov/ncea/cfm/recordisplay.cfmdeid=194584.
91. Isola, D., I. Kimber., K. Sarlo., J. Lalko, I.G. Sipes.: Chemical respiratory allergy and occupational asthma: what are the key areas of uncertainty J. Appl. Toxicol. 28 (3): 249-253 (2008).
92. Kimber, I., J.S. Pichowski., C.J. Betts., M. Cumberbatch., D.A. Basketter, R.J. Dearman.: Alternative approaches to the identification and characterization of chemical allergens. Toxicol. In Vitro 15 (4-5): 307-312 (2001).
93. Seed, M.J., P. Cullinan, R.M. Agius.: Methods for the prediction of low-molecular-weight occupational respiratory sensitizers. Curr. Opin. Allergy Clin. Immunol. 8 (2): 103-109 (2008).
94. Enoch, S.J., M.J. Seed., D.W. Roberts., M.T. Cronin., S.J. Stocks, R.M. Agius.: Development of mechanism-based structural alerts for respiratory sensitization hazard identification. Chem. Res. Toxicol. 25 (11): 2490-2498 (2012).
95. Roggen, E.L.: In vitro approaches for detection of chemical sensitization. Basic Clin. Pharmacol. Toxicol. 115 (1): 32-40 (2014).
96. Teubner, W., A. Mehling., P.X. Schuster. et al.: Computer models versus reality: how well do in silico models currently predict the sensitization potential of a substance. Regul. Toxicol. Pharmacol. 67 (3): 468-485 (2013).
97. Naumann, B.D., E.V. Sargent., B.S. Starkman., W.J. Fraser., G.T. Becker, G.D. Kirk.: Performance-based exposure control limits for pharmaceutical active ingredients. Am. Ind. Hyg. Assoc. J. 57 (1): 33-42 (1996).
98. NIOSH.: Current Intelligence Bulletin 61: A Strategy for Assigning New NIOSH Skin Notations. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH). Publication No. 09-147, 2009.
99. Dotson, G.S., C.P. Chen., B. Gadagbui., A. Maier., H.W. Ahlers, T.J. Lentz.: The evolution of skin notations for occupational risk assessment: a new NIOSH strategy. Regul. Toxicol. Pharmacol. 61 (1): 53-62 (2011).
100. UNECE (United Nations Economic Commission) Globally harmonized system of classification and labelling of chemicals (GHS): 4th revised edition. Available at http://www.unece.org/trans/danger/publi/ghs/ghsrev04/04filese.html.
101. ACGIH (American Conference of Governmental Industrial Hygienists.: Introduction to the Chemical Substances: Definitions and Notations. Cincinnati, OH: American Conference of Governmental Industrial Hygienists. CD-ROM, 2014.
102. NIOSH.: Qualitative Risk Characterization and Management of Occupational Hazards: Control Banding (CB). A Literature Review and Critical Analysis. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH). Publication No. 09-152, 2009.
103. Zalk, D.M, D.I. Nelson.: History and evolution of control banding: A review. J. Occup. Environ. Hyg. 5 (5): 330-346 (2008).
104. AIHA.: The Occupational Environment: Its Evaluation, Control, and Management. Falls Church, VA: American Industrial Hygiene Association, 2011.
105. Lacasse, Y, Y. Cormier.: Hypersensitivity pneumonitis. Orphanet. J. Rare Dis. 1: 25 (2006).
106. Ott, M.G.: Occupational asthma, lung function decrement, and toluene diisocyanate (TDI) exposure: a critical review of exposure-response relationships. Appl. Occup. Environ. Hyg. 17 (12): 891-901 (2002).
107. Simons, F.E., L.R. Ardusso., V. Dimov. et al.: World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base. Int. Arch. Allergy Immunol. 162 (3): 193-204 (2013).
108. EPA, Design for the environment program alternatives: assessment criteria for hazard evaluation. Available at http://epa.gov/dfe/alternativesassessmentcriteriaforhazardeval.pdf.
109. OSHA. Safety and Health Management Systems eTool. Available at, https://www.osha.gov/SLTC/etools/safetyhealth/comp3.html.
110. Basketter, D.A.: The human repeated insult patch test in the 21st century: a commentary. Cutan. Ocul. Toxicol. 28 (2): 49-53 (2009).
111. Zhai, H, H.I. Maibach.: Dermatotoxicology. Boca Raton, FL: CRC Press LLC, 2004.
112. Cal/OSHA, Sensitizing substances: advisory meetings. Available at, http://www.dir.ca.gov/DOSH/DoshReg/5179Meetings.html.
113. EC Regulation (EC) No 1272/2008 of the European Parliament and of The Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/ECC and 1999/45/EC, and amending Regulation (EC) No 1907/2006. Available at http://eur-lex.europa.eu/LexUriServ/LexUriServ.douri=OJ:L:2008:353:00011355:EN:PDF.